The SoRCE Program aims to improve access to and quality of sickle cell disease care and community services, while monitoring quality-of-life indicators.
Approach:
Regional hubs: HRSA announced seven awards to establish Regional Coordinating Hubs, expanding its regional sickle cell care network from five regions to seven.
Local partnerships: Each hub will partner with at least three clinical-community spokes. Each spoke includes a clinical center and one or more community-based organizations.
Workforce support: HRSA intends to award a contract for nationwide training, capacity development, and technical assistance for regional partners, health centers, community-based organizations, and community health workers.
Key Findings:
Sickle cell disease affects approximately 100,000 people in the United States.
The article reports that more than 75% of people with sickle cell disease nationwide receive disease-modifying therapy, following HRSA’s earlier investments.
The awards were announced October 20, 2026, through HRSA’s Sickle Cell Disease Regional Care Excellence Program.
Interpretation:
HHS and HRSA describe the hubs as a way to connect clinical expertise with community partners and support access to care closer to where people live.
Limitations:
The context does not identify the award recipients or provide award amounts.
It does not report measured outcomes from the newly announced hubs.
